This Is MS Multiple Sclerosis Knowledge & Support Community

I guess they're saying the re-growth of these neurons is a good thing? And that the treatments that suppress inflammation might inhibit this re-growth?

All I can say is that you have an awesome memory. I vaguely remember it. I looked it up and that conversation was a full year ago.

You're referring to the "ccvi" thing that cheerleader and mrhodes40 are all excited about?....MS as a vascular disease?

Quote:
You're referring to the "ccvi" thing that cheerleader and mrhodes40 are all excited about?....MS as a vascular disease?

Yes, and unfortunately from that I get the feeling it is just another symptom. The venous issue starts in the white matter. Not that we can't make it better, Jeff has already done that. But perhaps not the complete answer we are all looking for. ?

A major challenge in multiple sclerosis research is to understand the cause or causes of remyelination failure and to devise ways of ameliorating its consequences. This requires appropriate experimental models. Although there are many models of acute demyelination, at present there are few suitable models of chronic demyelination. The taiep rat is a myelin mutant that shows progressive myelin loss and, by 1 year of age, its CNS tissue has many features of chronic areas of demyelination in multiple sclerosis: chronically demyelinated axons present in an astrocytic environment in the absence of acute inflammation. Using the taiep rat and a combination of X-irradiation and cell transplantation, it has been possible to address a number of questions concerning remyelination failure in chronic multiple sclerosis lesions, such as whether chronically demyelinated axons have undergone changes that render them refractory to remyelination and why remyelination is absent when oligodendrocyte progenitor cells (OPCs) are present. Our experiments show that (i) transplanted OPCs will not populate OPC-containing areas of chronic demyelination; (ii) myelination competent OPCs can repopulate OPC-depleted chronically demyelinated astrocytosed tissue, but this repopulation does not result in remyelination--closely resembling the situation found in some multiple sclerosis plaques; and (iii) the induction of acute inflammation in this non-remyelinating situation results in remyelination. Thus, we can conclude that axonal changes induced by chronic demyelination are unlikely to contribute to remyelination failure in multiple sclerosis. Rather, remyelination fails either because OPCs fail to repopulate areas of demyelination or because if OPCs are present they are unable to generate remyelinating oligodendrocytes owing to the presence of inhibitory factors and/or a lack of the stimuli required to activate these cells to generate remyelinating oligodendrocytes. This non-remyelinating situation can be transformed to a remyelinating one by the induction of acute inflammation.